Uflex Ltd Q4 FY2023 Concall Summary

Key Takeaways

• Record revenue, but EBITDA hit by FX: FY23 revenue was the highest ever, driven by record Indian volumes, yet EBITDA fell ~9% YoY to ~₹2,070 crores because of a ₹340+ crore forex loss from Egypt's devaluation and dollar strength.
• Packaging films cycle is turning: Q3 was the worst hit by a triple blow of new capacity, European energy inflation, and US rate hikes; Q4 was far better, and May sizing is improving further, though not yet at Q1 FY23 levels.
• Aseptic packaging is the standout: Volumes grew 116% YoY, utilization hit 93-94%, and debottlenecking is underway to push capacity from 700 to ~1,200 crore packs per year, though the 1,200 crore target may only materialize by end of FY24 or January 2024.
• Backward integration into PET chips is the strategic answer: A Panipat plant (by Q4 FY24) and a new Egypt plant ($70 mn, 200k tons) aim to make dependence on third-party PET chips "very, very miniscule" after three years of raw material pain.
• What to watch next quarter: Whether the packaging films recovery sustains into Q2, the pace of aseptic debottlenecking, and any margin guidance once management has visibility on the films business.

Packaging Films: The Cycle & The Recovery

• The Q3 trough: Demand in Europe and the US was hit simultaneously by consumers diverting spending to higher energy bills and mortgage EMIs, just as new industry capacity came online, causing both price erosion and volume softness.
• Peer pain validates the cycle: Management noted that packaging films peers saw Q3-to-Q4 EBITDA drops of 30-50% normally, with some down 80-85%, framing Uflex's relative performance as resilient.
• Sequential improvement: Q4 was far better than Q3, and April/May have been relatively far better than Q4, though sizing is not yet back to Q1 FY23 levels.
• Normalization timeline: Management expects European and US business to normalize only by Q3 or Q4 of FY24, as the benefit of energy prices returning to near-normal levels takes time to flow through to consumer spending and pricing power.
• India as a demand anchor: India's 6-month demand growth of 10-11% is sufficient to absorb one new plant, providing a floor while export markets recover.

Bhatia: "Q3 was probably the worst hit and that Q4 is far better. And as we go into the month of May now, we are seeing a better sizing not at the same level at which we had in Q1 of the last year but in Q1 of this year."

Aseptic Packaging: The High-Utilization Growth Engine

• Volume explosion: Aseptic packaging delivered 116% volume growth in FY23, with capacity utilization running at 93-94% and currently "much higher than existing capacity numbers."
• Debottlenecking roadmap: Management is adding one extruder to the existing plant, where printing capacity already exceeds extrusion capacity, targeting an increase from 700 crore packs/year to about 1,200 crore packs/year.
• Timeline: The debottlenecking is expected to materialize by end of FY24 or at best by January 2024, with utilization expected to reach 115-120% of declared capacity this year.
• Margin improvement: Both aseptic margins and flexible packaging business margins improved in the last 1 year in FY23, even as the broader packaging films segment suffered.
• Revenue opacity: Management declined to disclose aseptic packaging revenue numbers when asked by an analyst.

Backward Integration: The PET Chips Strategy

• The problem it solves: Uflex, as one of the world's largest polyester film players, suffered substantial margin loss over three years from raw material short supply, higher costs, and higher freight rates while buying all PET chips from third parties.
• Panipat PET chips plant: Advanced stage of commissioning, now expected by Q4 FY24, accelerated from the earlier April 2025 guidance.
• Egypt PET chips plant: Newly approved investment of ~$70 million for 200,000 tons capacity, intended to supply facilities in the Middle East, Nigeria, Dubai, and Poland, fulfilling ~60-70% of the group's requirement.
• End-state: Dependence on the market for PET chips will become "very, very miniscule," capturing margins currently lost to third-party suppliers and ensuring raw material availability.

Bhatia: "Our size today almost in the polyester films being almost the largest player in the world, I think we required a bit of protection or you can say a strategic investment to ensure the raw material availability. We've suffered enough in the last three years when the raw materials were in a short supply."

Forex: The Below-the-Line Drag

• The ₹340+ crore hit: Of the total FX loss, ~₹150 crores came from the announced devaluation by the Egyptian Central Bank; the remainder reflects the market pricing in further devaluation as dollar strength hits currencies like the Nigerian naira, Egyptian pound, and Mexican peso.
• Consolidation mechanics: The loss arises when converting local-currency profits into dollars and then dollars to rupees; in local-currency terms in Egypt, there is only a positive impact.
• No hedging planned: Management looked at hedging but concluded that reacting now would be counterproductive because forward covers are much more expensive than they were, and booking now could end up losing money.

Bhatia: "Sort of -- we looked at this. But reacting to a situation now, it's not going to help it. So you may because today, if you talk about the forward covers are much more expensive than what they were. So if you book now and then you end up losing money on that as well so it's not the right move."

Capacity Additions & Capex

• Dharwad: 63,000 tons commissioned from April, expected to generate incremental revenue of ₹700-800 crores per annum with a margin profile similar to standalone, plus some cost savings from a larger, more efficient plant.
• Dubai CPP plant: 18,000 tons commissioned in Q4 FY23.
• Debt trajectory: Net debt stands at ~₹4,400 crores; management expects no substantial incremental increase even after funding the chips plant, with only ~₹500 crores of additional working capital debt likely.
• Capex envelope: For the next two years, capex requirement is ~₹700-750 crores; management will draw whatever debt is possible for that.
• Pricing: Overall price increases seen, with India prices moving up and global prices also impacted somewhat.

Guidance & Commitments

Key Metrics